Skye Peptides Reviews 2026: Reddit & COAs Overview Skye Peptides Reviews 2026: Reddit & COAs
(2022) Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial Chao Liao, et al
June 15, 2020
Developer: Eli Lilly and Company | Administration in Trials: Once-weekly subcutaneous injection First successful Phase 3 trial (TRIUMPH-4, topline Dec 2025): Up to 28.7% average body weight loss at 68 weeks (highest dose) in adults with obesity/overweight and knee osteoarthritis
Williams adds that new studies are uncovering benefits involving other chronic diseases, such as heart disease, Type 1 diabetes and polycystic ovary syndrome (PCOS)
Authoritative Sources Official product and guideline sources provide the most reliable details on indications, contraindications, and warnings